-
Bit by bit, Lundbeck trims fat from production costsOutsourcing to cut costs? Shipping work to China? No need, says Lundbeck. The Danish drugmaker has slashed its own manufacturing costs25% over the past 5 years, the Financial Times reports, saving2012/1/18
-
J&J whistleblower testifies in TX Risperdal caseAs the Risperdal marketing trial grinds on in Texas, a whistleblower took the stand to testify he was fired for raising questions. Allen Jones, who leveled allegations of mismarketing against Johnso2012/1/17
-
Numbers hint that Pfizer's Lipitor strategy may workThe latest figures on Lipitor sales suggest that Pfizer's ($PFE) aggressive sales strategies might—just might—be working. As The Associated Press reports, new IMS Health numbers show sales plateauin2012/1/17
-
Nestle Said to Vie With Danone to Buy Pfizer Baby-Food UnitNestle SA (NESN) and Danone SA (BN) made first- round bids for Pfizer Inc. (PFE)’s baby-formula unit, putting two of Europe’s largest food companies in competition for the division, people with knowle2012/1/16
-
Novartis to restructure US business to strengthen competitive position in light of loss of Diovan® patent and announces charge fNovartis to restructure US business to strengthen competitive position in light of loss of Diovan® patent and announces charge for Rasilez®/Tekturna® US General Medicines restructurin2012/1/16
-
Foreign firms reap 60% of China's healthcare stimulusExperts on China have a cautionary bit of advice for drugmakers: The devil is in the details. On a top-line basis, China's pledge of a $125 billion investment in healthcare this year looks great. In2012/1/13
-
Pharma faces China healthcare challengePharma faces China healthcare challengeBy Benjamin A Shobert SAN FRANCISCO - Milling around the hotel lobby at the Sir Francis Drake hotel in downtown San Francisco are an ecle2012/1/13
-
Drug Reps Soften Their Sales PitchesBy JONATHAN D. ROCKOFF GREENSBORO, N.C.—One thing was noticeably absent from a recent visit that an Eli Lilly & Co. sales representative paid to a psychiatrist here: a sales pitch. Michaelene G2012/1/12
-
Glaxo Is Keen to Advance Rest of OTC Asset Sale, CFO SaysGlaxoSmithKline Plc (GSK) is trying to sell its remaining over-the-counter medicine brands as quickly as possible, Chief Financial Officer Simon Dingemans said. Prestige Brands Holdings Inc. (PBH),2012/1/12
-
FDA: Endo opioids may be mixed in Novartis OTC packagesThe FDA has added its two cents to the Novartis ($NVS)consumer-drug recall. The agency has issued an advisory to healthcare professionals and patients that says some Endo Pharmaceuticals ($ENDP)pain2012/1/12